Directory
>
Angela Keightley
Angela Keightley
Vice President, Assay Development | BlueRock Therapeutics
Old Toronto, Ontario, Canada
Angela Keightley
Summary
Angela Keightley is a seasoned leader in the biotechnology sector with over 15 years of experience in scientific management and drug development. Currently serving as Vice President of Analytical Development at BlueRock Therapeutics, she has a proven track record in overseeing preclinical and clinical studies for innovative therapies, including cellular and gene therapies. Angela excels at fostering multidisciplinary teams to achieve project goals under tight deadlines, showcasing her strong leadership and communication skills. She has successfully launched a new molecular testing business area and is passionate about scientific innovation and regulatory compliance. Her educational background includes a Ph.D. in Pathology and Molecular Genetics from Queen's University. Angela is also a recognized thought leader, having presented at numerous biotechnology conferences and published several research articles.
Angela Keightley
Work Experience
Vice President, Assay Development at
BlueRock Therapeutics
January 2022 - Present
Senior Director, Assay Development at
BlueRock Therapeutics
January 2020 - March 2022
Director, Assay Development at
BlueRock Therapeutics
January 2018 - December 2019
Director, Genetic Toxicology at
Nucro-Technics Inc.
January 2015 - January 2017
Principal Scientist, Immunology (Molecular Biology) at
Charles River Laboratories
January 2006 - January 2014
Senior Research Scientist, Immunology (Molecular Biology) at
Charles River Laboratories
January 2005 - December 2005
Research Scientist, Immunology at
Charles River Laboratories
July 2003 - December 2004
Scientist, Genetic Toxicology at
Charles River Laboratories
September 2001 - June 2003
Post-Doctoral Fellow, Department of Medicine at
University Of Toronto
January 2000 - January 2001
Angela Keightley
Education
Queen's University, Ph.D.
January 1994 - January 2000
Trent University, Honours Bachelor Of Science (Hbsc)
January 1989 - January 1993
Frequently Asked Questions about Angela Keightley
What is Angela Keightley email address?
Angela Keightley's primary email address is **********@bluerocktx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Angela Keightley work for?
Angela Keightley is a Vice President, Assay Development at BlueRock Therapeutics, a company specializing in Commercial physical research.
Where Angela Keightley graduated from?
Angela Keightley holds a degree in Pathology, Molecular Genetics from Queen's University.
How can I directly contact Angela Keightley?
To contact Angela Keightley directly, you can use the email address **********@bluerocktx.com. Complete contact information is available upon registration with Muraena.
Who is Angela Keightley?
Angela Keightley is a seasoned leader in the biotechnology sector with over 15 years of experience in scientific management and drug development. Currently serving as Vice President of Analytical Development at BlueRock Therapeutics, she has a proven track record in overseeing preclinical and clinical studies for innovative therapies, including cellular and gene therapies. Angela excels at fostering multidisciplinary teams to achieve project goals under tight deadlines, showcasing her strong leadership and communication skills. She has successfully launched a new molecular testing business area and is passionate about scientific innovation and regulatory compliance. Her educational background includes a Ph.D. in Pathology and Molecular Genetics from Queen's University. Angela is also a recognized thought leader, having presented at numerous biotechnology conferences and published several research articles.
Angela`s contact details
**********@bluerocktx.com
Colleagues
Vice President, Preclinical Development & Clinical Pharmacology
SVP Process & Analytical Development
VP, Immunology
Vice President, Vendor Strategy & Partnerships
Vice President, GMP Manufacturing
Senior Vice President, Head of People & Culture
SVP, Global Head of Finance
Chief Scientific Officer
President and CEO
Board Member and SAB